Eli Lilly and Company (NYSE:LLY) is one of the best stocks to invest in for long-term growth. Eli Lilly and Company (NYSE:LLY ...

Eli Lilly said on Tuesday its experimental GLP-1 pill helped overweight adults with type 2 diabetes shed 10.5% of body weight in a late-stage trial, after recent data from another study of the drug in ...

Lilly said it’s moving ‘with urgency toward global regulatory submissions to potentially meet the needs of patients who are waiting.’ ...

The latest results from a trial of a pill form popular GLP-1 medications offer enough information for the Eli Lilly to request global regulatory approval this year, the company said Tuesday.

Mounjaro and other GLP-1 drugs may lower cancer risk in obese patients, according to a new study. Read more here.

COMMENT: The monthly cost of a private prescription for Mounjaro is set to exceed £300 from next month – worrying news for ...

With the price of Mounjaro set to almost triple in the UK, there are fears more and more people will turn to counterfeits.

Its amazing results have been hailed by Jeremy Clarkson, Whoopi Goldberg and The Telegraph’s own Allison Pearson, but from next month, the popular weight-loss drug Mounjaro could become inaccessible ...

Eli Lilly and Company (NYSE:LLY) is one of the best stocks to invest in for the long term. In a report released on August 13, Seamus Fernandez from Guggenheim maintained a Buy rating on Eli Lilly and ...

Vivienne Joy runs a community of hundreds of weight loss jab users and said the increased cost of Mounjaro had 'created chaos' ...

CheqUp said it had experienced a spike in interest from consumers wanting to switch or begin taking the medication.

Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.